This study provides novel insights into the immunopathogenesis of human cutaneous leishmaniasis (CL), demonstrating that Leishmania (Viannia) braziliensis distinctly modulates the release of extracellular vesicles (EV), including those derived from CD4+, CD8+, and CD14+ immune cells. The gene discussed is CD4; the disease is cutaneous leishmaniasis.